NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 2 year (est.)
- Value
- £22M
- Sector
- HEALTH
- Published
- 06 Jan 2026
- Delivery
- To 06 Jan 2028 (est.)
- Deadline
- n/a
Related Terms
Location
Edinburgh
2 buyers
- NHS National Services Scotland Edinburgh
46 suppliers
- Aguettant Bristol
- Martindale Pharma Romford
- Clinimed High Wycombe
- Optimum Medical Leeds
- Napp Pharmaceuticals Cambridge
- Hameln Pharma Gloucester
- Fresenius Kabi Runcorn
- Accord Healthcare North Harrow
- Gerot Lannach Ely
- Morningside Pharmaceuticals Leicester
- Qdem Pharmaceuticals Cambridge
- Ridge Pharma Reading
- Wockhardt Wrexham
- Aspire Pharma Petersfield
- Glenmark Pharmaceuticals Europe Watford
- Sandoz Surrey
- Zentiva Guildford England
- Kyowa Kirin International Newco Galashiels
- Unnamed None
- Teva Castleford
- Mercury Pharmaceuticals London
- B Braun Medical Sheffield
- Baxter Healthcare Berkshire
- Chiesi Manchester
- Drugsrus Harrow
- Accord Devon
- Arcadia Pharma Swansea
- Aspen Healthcare Solutions Birmingham
- Bowmed Ibisqus Wrexham
- Ennogen Healthcare Dartford
- Glaxosmithkline Brentford
- Hikma Pharmaceuticals London
- Intrapharm Laboratories Maidenhead
- Kent Pharmaceuticals Ashford
- Medreich Feltham
- Neon Healthcare Hertford
- Panpharma Liverpool
- Pfizer Tadworth
- Phoenix Labs Clonee
- Piramal Critical Care West Drayton
- SVP Pharma Norwich
- Stada UK Thornton & Ross Huddersfield
- Torbay Pharma Paignton
- Typharm Norwich
- Viatris UK Healthcare Hatfield
- Novumgen London
Description
This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Division
| 1 | Baclofen Intrathecal Injections Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 2 | Oxycodone Injections The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 3 | Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 4 | Oxycodone Hydrochloride Prolonged Release Tablets The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 5 | Buprenorphine Patches The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 6 | Fentanyl Tablets (Sublingual) The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 7 | Fentanyl Sf Tablet (Buccal) Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has not awarded this Lot. Award Criteria
| ||||||||
| 8 | Fentanyl Transdermal Patch Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 9 | Hydromorphone Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 10 | Lidocaine Chlorhexidine Gel Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 11 | Morphine Sulfate Modified-Release capsule (12Hr) Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 12 | Morphine Sulfate Modified-Release capsule (24Hr) The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 13 | Morphine Sulfate Modified-Release Tablet The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 14 | Oxycodone Hydrochloride Capsules The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 15 | Propofol Injection The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 16 | Tramadol Hydrochloride Modified Release Tablets The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 17 | Oxycodone Oral Solution The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 18 | Levobupivacaine (As Hydrochloride) Solution For Infusion The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Award Criteria
| ||||||||
| 19 | Supply to NHSS Pharmaceuticals "Specials" Service The supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service. The Authority has awarded each product line within this Lot to a single Framework Participant. Award Criteria
| ||||||||
| 20 | Levobupivacaine Solution for injection ampoules (unwrapped) Supply of Levobupivacaine solution for injection ampoules (unwrapped) all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant. Award Criteria
| ||||||||
| 21 | All other Analgesics and Anaesthetic Generic Medicines Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant. Award Criteria
|
Award Detail
| 1 | Aguettant (Bristol)
|
| 2 | Martindale Pharma (Romford)
|
| 3 | Clinimed (High Wycombe)
|
| 4 | Optimum Medical (Leeds)
|
| 5 | Napp Pharmaceuticals (Cambridge)
|
| 6 | Hameln Pharma (Gloucester)
|
| 7 | Fresenius Kabi (Runcorn)
|
| 8 | Accord Healthcare (North Harrow)
|
| 9 | Gerot Lannach (Ely)
|
| 10 | Morningside Pharmaceuticals (Leicester)
|
| 11 | Qdem Pharmaceuticals (Cambridge)
|
| 12 | Ridge Pharma (Reading)
|
| 13 | Wockhardt (Wrexham)
|
| 14 | Napp Pharmaceuticals (Cambridge)
|
| 15 | Aspire Pharma (Petersfield)
|
| 16 | Glenmark Pharmaceuticals Europe (Watford)
|
| 17 | Napp Pharmaceuticals (Cambridge)
|
| 18 | Sandoz (Surrey)
|
| 19 | Zentiva (Guildford England)
|
| 20 | Glenmark Pharmaceuticals Europe (Watford)
|
| 21 | Kyowa Kirin International Newco (Galashiels)
|
| 22 | Unnamed (None)
|
| 23 | Sandoz (Surrey)
|
| 24 | Teva (Castleford)
|
| 25 | Zentiva (Guildford England)
|
| 26 | Napp Pharmaceuticals (Cambridge)
|
| 27 | Mercury Pharmaceuticals (London)
|
| 28 | Napp Pharmaceuticals (Cambridge)
|
| 29 | Accord Healthcare (North Harrow)
|
| 30 | Gerot Lannach (Ely)
|
| 31 | Napp Pharmaceuticals (Cambridge)
|
| 32 | Qdem Pharmaceuticals (Cambridge)
|
| 33 | B Braun Medical (Sheffield)
|
| 34 | Baxter Healthcare (Berkshire)
|
| 35 | Fresenius Kabi (Runcorn)
|
| 36 | Chiesi (Manchester)
|
| 37 | Mercury Pharmaceuticals (London)
|
| 38 | Morningside Pharmaceuticals (Leicester)
|
| 39 | Teva (Castleford)
|
| 40 | Gerot Lannach (Ely)
|
| 41 | Martindale Pharma (Romford)
|
| 42 | Napp Pharmaceuticals (Cambridge)
|
| 43 | Wockhardt (Wrexham)
|
| 44 | Fresenius Kabi (Runcorn)
|
| 45 | Martindale Pharma (Romford)
|
| 46 | Accord Healthcare (North Harrow)
|
| 47 | Drugsrus (Harrow)
|
| 48 | Martindale Pharma (Romford)
|
| 49 | Mercury Pharmaceuticals (London)
|
| 50 | Martindale Pharma (Romford)
|
| 51 | Accord (Devon)
|
| 52 | Aguettant (Bristol)
|
| 53 | Arcadia Pharma (Swansea)
|
| 54 | Aspen Healthcare Solutions (Birmingham)
|
| 55 | Aspire Pharma (Petersfield)
|
| 56 | B Braun Medical (Sheffield)
|
| 57 | Baxter Healthcare (Berkshire)
|
| 58 | Bowmed Ibisqus (Wrexham)
|
| 59 | Chiesi (Manchester)
|
| 60 | Drugsrus (Harrow)
|
| 61 | Ennogen Healthcare (Dartford)
|
| 62 | Fresenius Kabi (Runcorn)
|
| 63 | Gerot Lannach (Ely)
|
| 64 | Glaxosmithkline (Brentford)
|
| 65 | Glenmark Pharmaceuticals Europe (Watford)
|
| 66 | Hameln Pharma (Gloucester)
|
| 67 | Hikma Pharmaceuticals (London)
|
| 68 | Intrapharm Laboratories (Maidenhead)
|
| 69 | Kent Pharmaceuticals (Ashford)
|
| 70 | Martindale Pharma (Romford)
|
| 71 | Medreich (Feltham)
|
| 72 | Mercury Pharmaceuticals (London)
|
| 73 | Morningside Pharmaceuticals (Leicester)
|
| 74 | Neon Healthcare (Hertford)
|
| 75 | Panpharma (Liverpool)
|
| 76 | Pfizer (Tadworth)
|
| 77 | Phoenix Labs (Clonee)
|
| 78 | Piramal Critical Care (West Drayton)
|
| 79 | SVP Pharma (Norwich)
|
| 80 | Teva (Castleford)
|
| 81 | Stada UK Thornton & Ross (Huddersfield)
|
| 82 | Torbay Pharma (Paignton)
|
| 83 | Typharm (Norwich)
|
| 84 | Viatris UK Healthcare (Hatfield)
|
| 85 | Wockhardt (Wrexham)
|
| 86 | Zentiva (Guildford England)
|
| 87 | Novumgen (London)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated values referred to in Section II.1.5 and all Lots covers the twenty-four (24) months framework duration and the twelve (12) month extension period of the framework agreement. (SC Ref:818056)
Reference
- FTS 000677-2026